CLIMACTERIC, vol.14, no.4, pp.482-487, 2011 (SCI-Expanded)
Article / Article
Science Citation Index Expanded (SCI-EXPANDED), Scopus
HORMONE REPLACEMENT THERAPY, DROSPIRENONE, ANGELIQ, DRY EYE, OCULAR DISEASE, NASAL AIRFLOW, HORMONE REPLACEMENT THERAPY, DRY EYE, LENS OPACITIES, RHINOMANOMETRIC OUTCOMES, REPRODUCTIVE FACTORS, MG DROSPIRENONE, TEAR FUNCTION, ESTROGEN, MENOPAUSE, AGE
Kütahya Health Sciences University Affiliated:
Background Hormones may have an impact on the incidence and course of dry-eye syndrome, and also nasal obstruction, especially in postmenopausal women. The aim of this study was to investigate the effects of drospirenone 2 mg + estradiol 1 mg (Angeliq (R), Bayer AG, Berlin, Germany) on ocular functions and nasal airflow in postmenopausal women.